Welcome to HEDD

The Human Epigenetic Drug Database (HEDD) is a comprehensive web-based database for epigenetic drugs, which focuses on the storage and integration of epigenetic drug datasets that were obtained from laboratory experiments that is essential for understanding the mechanism of action of these epigenetic drugs at a systematic level.

read more

Disease list

ConditionsDrug NameStatusNct NumberPhases
cutaneous T cell lymphoma
CTCL
Suberoylanilide hydroxamic acidCompletedapproved(N021991)
myelodysplastic syndromes
MDS
5-AzacytidineCompletedapproved(N050794)
myelodysplastic syndromes
MDS
5-Aza-2'-deoxycytidineCompletedapproved(N21790)
cardiac arrhythmiaProcainamideCompletedapproved(NDA 007335)
hypertensionhydralazineCompletedapproved(NDA 008303)
cutaneous T cell lymphoma
CTCL
RomidepsinCompletedapproved(NDA022393)
multiple myeloma
MM
PanobinostatCompletedapproved(NDA205353)
peripheral T-cell lymphoma
PTCL
BelinostatCompletedapproved(NDA206256)
Breast cancerPanobinostatTerminatedNCT00993642Phase 0
Advanced cancers5-Azacytidine
valproic acid
CompletedNCT00496444Phase 1
Brain metastasesTemozolomide
valproic acid
TerminatedNCT00437957Phase 1
HIV infectionsEnfuvirtide
valproic acid
TerminatedNCT00312546Phase 1
MDS5-Aza-2'-deoxycytidine CompletedNCT00796003Phase 1
Leukemia
MDS
5-Aza-2'-deoxycytidine CompletedNCT00049582Phase 1
Bladder cancer
breast cancer
melanoma
5-Aza-2'-deoxycytidine CompletedNCT00030615Phase 1
Esophageal
lung cancer
malignant mesothelioma
5-Aza-2'-deoxycytidine CompletedNCT00019825Phase 1
Leukemia5-Aza-2'-deoxycytidine CompletedNCT00042796Phase 1
MDS
leukemia
lymphoma
MM
5-Aza-2'-deoxycytidine CompletedNCT00002980Phase 1
Myeloproliferative disorders
leukemia
5-Aza-2'-deoxycytidine
Suberoylanilide hydroxamic acid
CompletedNCT00357708Phase 1
LymphomaSuberoylanilide hydroxamic acidCompletedNCT00771472Phase 1
Total Page:29 Page   of 29

About

pix

The Human Epigenetic Drug Database (HEDD) is a comprehensive web-based database for epigenetic drugs, which focuses on integrating epigenetic drug studies based Omics data from high through experiments that is essential for understanding the mechanism of action of these epigenetic drugs at a systematic level.

Copyright

©2016 Group of Computational Epigenomics and Bioinformatics, College of Life Science, Jilin Normal University, China

吉ICP备16005872号